Revolution Medicines RVMD
NASDAQ RVMD
$178.12 -21.58 (-10.81%)
As of: Nov 5, 2026 · 3:59 PM EST

Revolution Medicines (RVMD) Deferred Taxes (2020 - 2024)

Updated

Revolution Medicines (RVMD) reported Deferred Taxes of -$762,000 for Q4 2024, compared with -$43,000 a year earlier.

Analysis

Revolution Medicines (RVMD) Deferred Taxes (2020 - 2024) Analysis & Trends

Dating back to Q1 2020, Revolution Medicines' Deferred Taxes record includes 6 quarters.

  • By year, Deferred Taxes came in at -$3.91 million in FY2023, -$419,000 in FY2022 and -$375,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Eli Lilly 1,221.09 Bn 1,194.71 Bn 20.46 Bn -665.00 Mn
2 Johnson & Johnson 656.38 Bn 576.24 Bn 17.30 Bn -1.79 Bn
3 AbbVie 510.79 Bn 478.80 Bn 13.12 Bn -56.00 Mn
4 Merck 363.00 Bn 317.38 Bn 12.21 Bn -544.00 Mn
5 Novartis Ag 313.89 Bn 287.12 Bn - -
6 Astrazeneca 290.02 Bn 263.91 Bn 13.26 Bn -
7 Amgen 249.59 Bn 204.98 Bn 7.24 Bn -291.00 Mn
8 Gilead Sciences 208.15 Bn 183.26 Bn 6.73 Bn 202.00 Mn
9 Pfizer 170.74 Bn 118.10 Bn 12.56 Bn -860.00 Mn
10 Revolution Medicines 38.00 Bn 28.20 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -762,000.00
Dec 31, 2023 -43,000.00
Dec 31, 2022 -123,000.00
Dec 31, 2020 359,000.00
Jun 30, 2020 -18,000.00
Mar 31, 2020 -716,000.00
API Access

Revolution Medicines Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=RVMD&period=max&api_key=YOUR_API_KEY